Veracyte, Inc.
VCYT
$46.41
$0.140.30%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -11.21% | -30.24% | 115.02% | 2,052.76% | -113.91% |
| Total Depreciation and Amortization | -10.90% | 2.49% | 0.61% | -4.06% | 2.37% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.47% | 1,846.05% | -95.29% | -47.90% | 259.75% |
| Change in Net Operating Assets | 114.80% | -314.07% | -14.14% | 180.69% | 115.67% |
| Cash from Operations | 30.13% | -33.03% | 17.49% | 33.19% | 526.73% |
| Capital Expenditure | 3.48% | 21.64% | -35.39% | -117.11% | 29.30% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 91.45% | -10,560.17% | -97.66% | 4,707.44% | 102.12% |
| Cash from Investing | 89.41% | -2,256.56% | -111.25% | 21,645.98% | 99.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 208.34% | -22.08% | -39.39% | 219.24% | -38.86% |
| Repurchase of Common Stock | 54.14% | -155.92% | -30.03% | -18.24% | 74.82% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 162.44% | -4,348.99% | -105.01% | 625.97% | 91.27% |
| Foreign Exchange rate Adjustments | 55.17% | -583.33% | -80.00% | -89.53% | 674.32% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 136.60% | -311.49% | -51.05% | 187.70% | 163.16% |